Two cases of cranial arteritis are described in which the presence of formed visual hallucinations has been a significant factor in their clinical presentation and course. The purpose of this paper is to draw attention to this symptom-not previously reported-and to suggest a possible aetiology in view of the known pathology of cranial arteritis. It is now well recognized that the disease process, a panarteritis, may involve not only the superficial temporal branches and other divisions of the external carotid but also the internal carotid tree, and the subclavian, coronary, renal, mesenteric, pulmonary, and peripheral vasculature. A full consideration of the pathology, incidence, and symptoms of cranial arteritis will not be dealt with in the present report, since these are well described in previous publications (Horton, Magath, and Brown, 1932; Parsons-Smith, 1959; Simmons and Cogan, 1962 A temporal artery biopsy was not thought necessary in view of the previous response to treatment, as regards both symptoms and the diminution in the E.S.R. Prednisolone 30 mg./day orally was begun with immediate loss of the formed hallucinations, which up to the time of writing had not recurred on a continued dosage of 5 mg. of prednisolone b.d.
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Discussion
The incidence of intracranial complications of cranial arteritis would appear to be small, judging from the lack of published evidence to the contrary. Meadows (1954) described the cases of two patients with dementia and one with progressive failure of memory for two years preceding the onset of blindness. Symptoms of vertigo, tinnitus, and loss of hearing have been described (Font, 1960) as occurring in this condition, the cause being presumed to be occlusive involvement of the internal auditory artery. Parsons-Smith (1959) described series of 50 cases, four of which showed field loss (the type of field loss is not specified) due to cerebral lesions consistent with cranial arteritis.
The symptom of formed visual hallucinations experienced by the above two patients is assumed to be due to involvement of the cerebral cortex, particularly the temporal lobes, by this same occlusive vascular condition.
The onset and duration of the symptom vary greatly in the two cases. Case 1 demonstrated it as a premonitory symptom, 644 9. September 1967
Cranial Arteritis-Hart BRITUH associated initially with loss of unilateral vision and subsequently substantial loss of field in the unaffected eye, relieved by the administration of systemic corticosteroids: the hallucinations were a very temporary effect of cortical ischaemia relieved by prednisolone. In Case 2 the hallucinations occurred after an interval of two months, following severe bilateral loss of visual acuity, with no relief from corticosteroid therapy ; in this particular case it must be assumed that the occlusive process has been permanent. The time of onset of this symptom after ocular involvement is of interest since it corroborates previous descriptions in that the generalized effect of cranial arteritis may follow ocular involvement by an interval of one to six months. The rarity of visual hallucinations in the blind has been noted by Freeman and Williams (1953) and it should be stressed at this stage that the formed hallucinations experienced by these two patients in no way resemble the psychic disturbances of postoperative cataract patients in which the imagery promptly disappears on uncovering the eyes. Walsh (1957) is of the opinion that formed visual hallucinations are due to involvement of the temporal lobe, and cites both experimental and clinical evidence to substantiate this point. A differing view is held by Weinberger and Grant (1940) , who believe that no such strict localization exists within the cerebral hemispheres, such hallucinations representing psychological phenomena involving the total integrative activity of the mind, the formed imagery depending on consititutional factors, not on cortical psychic organization. In his summary, Walsh prefers to accept the localization of such phenomena to the temporal lobe, founded on the available experimental and clinical evidence. Both patients whose cases have been described show marked complacency to their respective visual symptoms, and it is postulated that this euphoria may also be connected with the intracranial occlusive episodes of cranial arteritis.
Summary
Two cases of cranial arteritis, both manifesting formed visual hallucinations as a disturbing symptom, are described. The mode of presentation differed; in one case this symptom preceded the onset of unilateral loss of visual acuity and subsequently gave warning of impending visual loss in the other eye, whereas in the second case this symptom followed the occurrence of bilateral loss of vision. The subject of visual hallucinations and their possible relation to the known intracranial vascular pathology of this disorder are discussed. Oestrogens are known to suppress lactation, and are often used for this purpose. The oral contraceptives currently available contain oestrogens and progestogens in varying doses. In some the progestin component itself has oestrogenic qualities (Paulsen, 1965) , and treatment with this group might be expected to impair lactation to a marked extent. Rice-Wray (1964) reported that in about half of the lactating mothers she studied the milk yield was diminished by oral contraceptives. This seems to be a dose-dependent effect, for Pincus (1965, p. 262) noted that the percentage inhibited decreased from 77 to 15 as the norethynodrel dose was reduced from 20 to 2.5 mg./day. Satterthwaite (1964) thought that a 2.5-mg. dose of norethynodrel did not, significantly affect lactation, but in her study there were no controls and the small number of patients makes generalization difficult.
Of oral contraceptive preparations currently available Norinyl-1 (norethisterone 1 mg. and mestranol 0.05 mg.) has the lowest total steroid content. Furthermore, norethisterone is antioestrogenic in some of its effects. In view of Rice-Wray's findings and Pincus's suggestion of a dose-dependent effect it seemed important to test the action of Norinyl-1.
The immediate post-partum period is the most convenient time to advise on contraception, and if the agent can be prescribed at this time follow-up problems are considerably reduced. This aspect is of prime importance in the developing countries, where the immediate post-partum period may be the only opportunity for contraceptive treatment, and where breast milk may be the infants' only source of protein.
Most studies of the effects of oral contraceptives on lactation have not been controlled, and since many factors influence lactation this reduces their value.
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Methods
All mothers delivered in the obstetrics unit of St. Joseph's Hospital, Copenhagen, during the period July-September 1966 entered the trial, with the exception of (1) mothers who it was decided, before or immediately after delivery, should not attempt to breast-feed, and (2) mothers who gave birth to infants weighing less than 2,000 g.
A total of 451 women took part in the trial. Tablets were supplied by Syntex Pharmaceuticals Limited, England, in small containers marked only with a code number and containing 21 tablets. The code 'was not disclosed in Denmark until the trial had been completed, but it was known that some of the tablets were Norinyl-1 and others were inert placebo tablets.
Each woman included in the trial received one tablet daily from the day after the birth of her child until discharge from hospital on the eighth day.
The relevant details of each case were recorded on a form which included the mother's previous history of breast-feeding, the code number of the tablets taken, and the baby's birth
